July 31 (Reuters) – Medical technology firm Siemens Healthineers cut its 2026 revenue growth forecast on Friday to a range of 3.5% to 4.0%, as China’s procurement policy weighs on its diagnostics business.
China’s volume-based procurement and lower reimbursement rates have depressed prices and sales volumes in the country’s diagnostics market.
• The German company also raised outlook for adjusted earnings per share to between €2.35 and €2.45, reflecting the amount of U.S. tariff refunds
• It had previously forecast annual revenue growth of 5% to 6% and earnings per share in a range of €2.20 to €2.40
• Its third-quarter revenue rose 1.8% to €5.76 billion ($6.63 billion) and missed an LSEG consensus estimate by 0.8%
• The Erlangen-based firm also posted a year-on-year increase in its adjusted operating profit margin to 19.1% from 16.8%
($1 = 0.8692 euros)
(Reporting by Simon Ferdinand Eibach and Kira Britten, editing by Milla Nissi-Prussak)
